色素-话题@MedSci

#色素#

654篇内容 | 6194人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680505, encodeId=c44e16805054b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JCO：Selumetinib联合Dacarbazine治疗转移性葡萄膜黑色素瘤, objectType=article, longId=132597, objectId=147213259e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=147213259e0e, replyNumber=0, likeNumber=61, createdTime=2018-10-30, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=147213259e0e, moduleTitle=JCO：Selumetinib联合Dacarbazine治疗转移性葡萄膜黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=147213259e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680458, encodeId=0e3d168045828, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Am Acad Dermatol：甲下黑色素瘤与甲下鳞状细胞癌的碰撞, objectType=article, longId=118289, objectId=8c7411828910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c7411828910, replyNumber=0, likeNumber=53, createdTime=2018-01-10, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c7411828910, moduleTitle=J Am Acad Dermatol：甲下黑色素瘤与甲下鳞状细胞癌的碰撞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c7411828910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680519, encodeId=933a168051953, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=【盘点】黑色素瘤近期重要研究进展汇总, objectType=article, longId=136118, objectId=3288136118ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3288136118ad, replyNumber=0, likeNumber=49, createdTime=2019-01-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3288136118ad, moduleTitle=【盘点】黑色素瘤近期重要研究进展汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3288136118ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680443, encodeId=ae061680443de, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Biomed Res Int：调控miR-219-5p的表达或是黑色素瘤的一种新的治疗策略, objectType=article, longId=112497, objectId=f19511249eeb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f19511249eeb, replyNumber=0, likeNumber=75, createdTime=2018-04-13, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f19511249eeb, moduleTitle=Biomed Res Int：调控miR-219-5p的表达或是黑色素瘤的一种新的治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f19511249eeb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680464, encodeId=6b30168046471, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=个性化癌症疫苗“搞定”黑色素瘤, objectType=article, longId=119048, objectId=1c0911904866, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c0911904866, replyNumber=0, likeNumber=56, createdTime=2018-02-27, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c0911904866, moduleTitle=个性化癌症疫苗“搞定”黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c0911904866)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680500, encodeId=c62a16805003d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Nature：红头发的人易得黑色素瘤被揭密, objectType=article, longId=130028, objectId=9b2d13002890, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b2d13002890, replyNumber=0, likeNumber=110, createdTime=2018-12-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b2d13002890, moduleTitle=Nature：红头发的人易得黑色素瘤被揭密, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b2d13002890)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680528, encodeId=f5bc1680528e2, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Arch Biochem Biophys：ID2通过p-ERK1/2-ID2-NRF2途径保护视网膜色素上皮细胞（RPE）免受氧化损伤, objectType=article, longId=138643, objectId=2bb91386434a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bb91386434a, replyNumber=0, likeNumber=44, createdTime=2018-12-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bb91386434a, moduleTitle=Arch Biochem Biophys：ID2通过p-ERK1/2-ID2-NRF2途径保护视网膜色素上皮细胞（RPE）免受氧化损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bb91386434a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680517, encodeId=5635168051e4c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JAMA Oncology：普萘洛尔能预防厚皮肤黑色素瘤疾病的复发吗？, objectType=article, longId=135664, objectId=276413566441, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=276413566441, replyNumber=0, likeNumber=47, createdTime=2018-12-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=276413566441, moduleTitle=JAMA Oncology：普萘洛尔能预防厚皮肤黑色素瘤疾病的复发吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=276413566441)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680445, encodeId=adce16804454b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：新治疗组织黑色素瘤扩散, objectType=article, longId=113288, objectId=299811328858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=299811328858, replyNumber=0, likeNumber=92, createdTime=2018-02-05, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=299811328858, moduleTitle=NEJM：新治疗组织黑色素瘤扩散, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=299811328858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680492, encodeId=48b21680492af, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：新辅助化疗联合辅助达拉菲尼和曲美替尼对比标准疗法治疗高危型、可手术切除的黑色素瘤的效果。, objectType=article, longId=126919, objectId=c97a126919c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c97a126919c3, replyNumber=0, likeNumber=14, createdTime=2018-02-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c97a126919c3, moduleTitle=Lancet Oncol：新辅助化疗联合辅助达拉菲尼和曲美替尼对比标准疗法治疗高危型、可手术切除的黑色素瘤的效果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c97a126919c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680477, encodeId=c98116804e786, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Autophagy：自噬可以调节黑色素瘤发展, objectType=article, longId=123225, objectId=5a0c123225f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a0c123225f1, replyNumber=0, likeNumber=61, createdTime=2018-09-17, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a0c123225f1, moduleTitle=Autophagy：自噬可以调节黑色素瘤发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a0c123225f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680465, encodeId=3afb16804657d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：Dabrafenib联合Trametinib可显著降低III期BRAF V600突变黑色素瘤患者的术后复发风险, objectType=article, longId=119397, objectId=b09511939ebc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b09511939ebc, replyNumber=0, likeNumber=71, createdTime=2018-08-10, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b09511939ebc, moduleTitle=NEJM：Dabrafenib联合Trametinib可显著降低III期BRAF V600突变黑色素瘤患者的术后复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b09511939ebc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680429, encodeId=e00416804293d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Am Acad Dermatol：PDL1表达与黑色素瘤的侵袭性和进展相关, objectType=article, longId=107476, objectId=0a7010e4768e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a7010e4768e, replyNumber=0, likeNumber=69, createdTime=2018-02-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a7010e4768e, moduleTitle=J Am Acad Dermatol：PDL1表达与黑色素瘤的侵袭性和进展相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a7010e4768e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680502, encodeId=80151680502c9, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=EUR J Cancer：ipilimumab在NY-ESO-1阳性黑色素瘤患者中的作用, objectType=article, longId=131023, objectId=c06d1310231d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c06d1310231d, replyNumber=0, likeNumber=65, createdTime=2018-03-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c06d1310231d, moduleTitle=EUR J Cancer：ipilimumab在NY-ESO-1阳性黑色素瘤患者中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c06d1310231d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680490, encodeId=910b168049088, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Clin Oncol：服用帕姆单抗达到完全缓解的晚期黑色素瘤患者停药后，缓解时间还会持续多久？, objectType=article, longId=126191, objectId=019c1261914a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=019c1261914a, replyNumber=0, likeNumber=69, createdTime=2018-11-14, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=019c1261914a, moduleTitle=J Clin Oncol：服用帕姆单抗达到完全缓解的晚期黑色素瘤患者停药后，缓解时间还会持续多久？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=019c1261914a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680421, encodeId=cfa016804210b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=【盘点】近期黑色素瘤重要研究进展一览, objectType=article, longId=105381, objectId=07b81053813c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07b81053813c, replyNumber=0, likeNumber=72, createdTime=2017-08-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07b81053813c, moduleTitle=【盘点】近期黑色素瘤重要研究进展一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07b81053813c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680416, encodeId=19fe168041611, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Mayo Clin Proc：帕金森病与黑色素瘤竟然有瓜葛！, objectType=article, longId=104703, objectId=7e13104e035a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e13104e035a, replyNumber=0, likeNumber=75, createdTime=2018-02-07, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e13104e035a, moduleTitle=Mayo Clin Proc：帕金森病与黑色素瘤竟然有瓜葛！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e13104e035a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680430, encodeId=c06b1680430a3, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=PLoS One：丛生蛋白对色素性视网膜炎大鼠模型中杆状光感受器具有保护作用！, objectType=article, longId=107941, objectId=c28c10e941b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c28c10e941b1, replyNumber=0, likeNumber=72, createdTime=2017-09-25, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c28c10e941b1, moduleTitle=PLoS One：丛生蛋白对色素性视网膜炎大鼠模型中杆状光感受器具有保护作用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c28c10e941b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680503, encodeId=da971680503a3, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=白血病药物的重新使用能够预防黑色素瘤的转移, objectType=article, longId=131450, objectId=49bb1314509c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49bb1314509c, replyNumber=0, likeNumber=60, createdTime=2018-10-18, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49bb1314509c, moduleTitle=白血病药物的重新使用能够预防黑色素瘤的转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49bb1314509c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680512, encodeId=dcc616805124e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet：推荐将nivolumab联合伊匹单抗作为无症状未治疗过的黑色素瘤脑转移患者的一线疗法, objectType=article, longId=133714, objectId=5089133e14b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5089133e14b6, replyNumber=0, likeNumber=83, createdTime=2018-04-06, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5089133e14b6, moduleTitle=Lancet：推荐将nivolumab联合伊匹单抗作为无症状未治疗过的黑色素瘤脑转移患者的一线疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5089133e14b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

JCO：Selumetinib联合Dacarbazine治疗转移性葡萄膜黑色素瘤

2018-10-30

sunylz (审核中...)

前往app查看评论内容

#色素#

J Am Acad Dermatol：甲下黑色素瘤与甲下鳞状细胞癌的碰撞

2018-01-10

sunylz (审核中...)

前往app查看评论内容

#色素#

【盘点】黑色素瘤近期重要研究进展汇总

2019-01-16

sunylz (审核中...)

前往app查看评论内容

#色素#

Biomed Res Int：调控miR-219-5p的表达或是黑色素瘤的一种新的治疗策略

2018-04-13

sunylz (审核中...)

前往app查看评论内容

#色素#

个性化癌症疫苗“搞定”黑色素瘤

2018-02-27

sunylz (审核中...)

前往app查看评论内容

#色素#

Nature：红头发的人易得黑色素瘤被揭密

2018-12-01

sunylz (审核中...)

前往app查看评论内容

#色素#

Arch Biochem Biophys：ID2通过p-ERK1/2-ID2-NRF2途径保护视网膜色素上皮细胞（RPE）免受氧化损伤

2018-12-22

sunylz (审核中...)

前往app查看评论内容

#色素#

JAMA Oncology：普萘洛尔能预防厚皮肤黑色素瘤疾病的复发吗？

2018-12-04

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：新治疗组织黑色素瘤扩散

2018-02-05

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：新辅助化疗联合辅助达拉菲尼和曲美替尼对比标准疗法治疗高危型、可手术切除的黑色素瘤的效果。

2018-02-28

sunylz (审核中...)

前往app查看评论内容

#色素#

Autophagy：自噬可以调节黑色素瘤发展

2018-09-17

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：Dabrafenib联合Trametinib可显著降低III期BRAF V600突变黑色素瘤患者的术后复发风险

2018-08-10

sunylz (审核中...)

前往app查看评论内容

#色素#

J Am Acad Dermatol：PDL1表达与黑色素瘤的侵袭性和进展相关

2018-02-01

sunylz (审核中...)

前往app查看评论内容

#色素#

EUR J Cancer：ipilimumab在NY-ESO-1阳性黑色素瘤患者中的作用

2018-03-01

sunylz (审核中...)

前往app查看评论内容

#色素#

J Clin Oncol：服用帕姆单抗达到完全缓解的晚期黑色素瘤患者停药后，缓解时间还会持续多久？

2018-11-14

sunylz (审核中...)

前往app查看评论内容

#色素#

【盘点】近期黑色素瘤重要研究进展一览

2017-08-04

heli0118 (审核中...)

前往app查看评论内容

#色素#

Mayo Clin Proc：帕金森病与黑色素瘤竟然有瓜葛！

2018-02-07

sunylz (审核中...)

前往app查看评论内容

#色素#

PLoS One：丛生蛋白对色素性视网膜炎大鼠模型中杆状光感受器具有保护作用！

2017-09-25

sunylz (审核中...)

前往app查看评论内容

#色素#

白血病药物的重新使用能够预防黑色素瘤的转移

2018-10-18

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet：推荐将nivolumab联合伊匹单抗作为无症状未治疗过的黑色素瘤脑转移患者的一线疗法

2018-04-06

科室
- - 订阅+
  - 更多科室
工具
服务